Heather Hampel completed her Bachelor of Science degree in Molecular Genetics at the Ohio State University in 1993. She attained her Master’s degree in Human Genetics from Sarah Lawrence College in 1995. She received certification from the American Board of Genetic Counseling in 1996. She worked as a cancer genetic counselor at Memorial Sloan- Kettering Cancer Center before moving to The Ohio State University Comprehensive Cancer Center (OSUCCC) in 1997.
Currently, Heather is a Professor in the Department of Internal Medicine and Associate Director of the Division of Human Genetics. She is also the Associate Director of Biospecimen Research for the OSUCCC.
She was the study coordinator for the Columbus-area Lynch syndrome study which determined the frequency of Lynch syndrome among newly diagnosed patients with these cancers. This study culminated in first author publications in the New England Journal of Medicine in May of 2005, Cancer Research in August of 2006, and the Journal of Clinical Oncology in December of 2008. She is now the PI of the Ohio Colorectal Cancer Prevention Initiative which is screening colorectal cancer patients from 50 hospitals throughout the state for hereditary cancer syndromes. Heather Hampel was on the Board of Directors for the American Board of Genetic Counseling from 2006-2011, serving as President in 2009 and 2010. She is President-elect of the Collaborative Group of the Americas on Inherited Colorectal Cancer and a Steering Committee member of the National Colorectal Cancer Roundtable.
Dr. Camacho’s philosophy is to approach patients with hope, with the understanding that cancer can be a fatal disease process. It is therefore critical that patients use their healing process as a spiritual journey with an enormous potential for individual learning and growth. “We want cancer to be experienced as a great opportunity to love and receive love. To thank God for our loved ones, for each minute, every smile, any moment… and most importantly, for the life lived.”
Dr. Camacho has served as a principal investigator or co-investigator for more than 70 clinical trials. He has co-authored over 100 National and International scientific abstracts. Dr. Camacho has published the results of his basic and clinical research experience in journals like The New England Journal of Medicine, The Journal of Clinical Oncology, Cancer, Annals of Tropical Medicine and Parasitology, British Journal of Cancer, Annals of Oncology and other peer - reviewed medical journals. He is the founder of the Center for Oncology and Blood Disorders in Houston.
Laura Zitella, MS, RN, ACNP-BC, AOCN
Luis Camacho, MD
Patricia A. Mangan, MSN, CRNP
Patricia Jakel, RN, is an Advance Practice Nurse for the Solid Tumor Program at UCLA Healthcare. She oversees the care of 25-35 patients receiving chemotherapy, radiation therapy, symptom management and End of Life care. Ms. Jakel mentors new nurses to the art of oncology nursing.
Ms Jakel earned her Master’s Degree in Nursing in 1991 from the University of California, Los Angeles. She is certified as an Advanced Oncology Nurse by the Oncology Nursing Society, and received the Advanced Practice Nurse of the Year Award in 2015 from the Los Angeles Chapter. Ms. Jakel is involved in nursing research looking at moral distress and compassion fatigue. She is a frequent speaker on symptom management, new oncology treatments, and ethics. She has numerous publications on Ethics and Oncology Nursing, Compassion Fatigue and Chemotherapy agents.
Patricia Jakel, RN, MN, AOCNÒ
Dr. Anne Katz is the certified sexuality counselor and Clinical Nurse Specialist at Cancer Care Manitoba.
Dr. Katz is the editor of the Oncology Nursing Forum, the premier research journal of the Oncology Nursing Society. She was inducted into the American Academy of Nursing in 2014.
She has educated thousands of health care providers and cancer survivors about cancer, sexuality, and survivorship and is an avid blogger for ASCO Connections.
She is the author of 13 books for health care providers and consumers on the topics of illness, sexuality and cancer survivorship.
Teresa Knoop is an Assistant Director of the Clinical Trials Shared Resource at the Vanderbilt-Ingram Cancer Center in Nashville, TN. She graduated from Murray State University in Murray,KY with a BSN and earned her Master’s Degree in Nursing from the Vanderbilt University School of Nursing. Teresa is an Advanced Oncology Certified Nurse through the Oncology Nursing Society and is a Certified Clinical Research Professional through the Society of Clinical Research Associates. She has published articles in nursing journals and speaks frequently on the topics of molecularly targeted cancer therapies and cancer clinical trials.
Madeleine Kuiper, NP
Dr. Donna L. Berry is a Professor of Biobehavioral Nursing and Health Informatics at the University of Washington in Seattle. Dr. Berry practiced as an oncology nurse specialist prior to receiving her PhD from the University of Washington in 1992. Dr. Berry leads several studies to improve the human experience of having a cancer diagnosis, ranging from making treatment decisions to managing cancer symptoms and side effects.
Patricia A. Mangan, MSN, CRNP, is Nurse Lead of the Hematologic Malignancies and Stem Cell Transplant Programs at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia. In addition, she works in collaborative practice with Edward A. Stadtmauer, MD, focusing on the care of patients with multiple myeloma and other blood cancers. She is also a Clinical Academic Associate at the University of Pennsylvania’s School of Nursing. Ms. Mangan is a member of the Nursing Leadership Board of the International Myeloma Foundation.
She earned her master of science in nursing degree from the University of Pennsylvania and is a board certified registered nurse practitioner (CRNP) and clinical nurse specialist.
An invited speaker on a broad number of topics that deal with bone marrow transplant, cellular immunotherapy and the care of patients with hematologic malignancies, Patricia Mangan has lectured on both the local, national and international level. The results of her work have appeared in such peer-reviewed journals as Blood, Nursing, Bone Marrow Transplant, Clinical Journal of the Oncology Nursing Society (CJON), The Lancet Haematology and The Nurse Practitioner.
Copyright 2017 GLAONS All rights reserved.
Click on each link below for a printable file.
Donna L. Berry, PhD, RN, AOCN®, FAANy
Madelaine Kuiper is an Advanced Registered Nurse Practitioner with 8 years of experience in the diagnosis, treatment, management and research of patients with breast cancer. She has 25 years of experience as a Registered Nurse in Hematology/Oncology as well as administrative experience in personnel management. She received both her Bachelors and Masters in Nursing from UCLA and is currently an NP at the UCLA Santa Monica Hematology/Oncology Breast Program.
Laura J. Zitella, MS, RN, ACNP-BC, AOCN, is the Lead Advanced Practice Provider and Nurse Practitioner for inpatient hematology/oncology at Stanford Health Care and Stanford Cancer Institute. Ms. Zitella received her Masters of Science and Bachelors of Science in Nursing from the University of Illinois. She is
certified as an Acute Care Nurse Practitioner and Advanced Oncology Certified Nurse. Ms. Zitella leads an inpatient medical service of nurse practitioners responsible for the care of hospitalized patients with malignancies. She is actively involved in program development, evidence-based practice, electronic
medical record and quality improvement initiatives at the Stanford Cancer Institute and the Stanford Center for Advanced Practice. She also serves as Clinical Associate Professor in the Department of Physiological Nursing at the University of California San Francisco.
Ms. Zitella is a published author, presenter, and educator on various oncology topics, particularly hematologic malignancies, the administration of chemotherapy and biotherapy, and supportive care topics such as infection, anemia, and oncologic emergencies. She also is an active member of the
Oncology Nursing Society, the Advanced Practitioner Society of Hematology and Oncology, and the American Association of Nurse Practitioners.